CVS241122C80000
- 0.02
- 0.000.00%
CVS Health Newsroom
CVS Health Appoints 4 New Board Members Following Agreement With Glenview Capital
CVS Health's 2025 'Less Certain' Following 2024 Guidance Withdrawal, Changes in Leadership, RBC Capital Says
Today's Pre-Market Movers and Top Ratings | NVDA, TSLA, CVS, LBRT and More
CVS Health Price Target Raised to $66.00/Share From $60.00 by Wells Fargo
CVS Health Raised to Overweight From Equal-Weight by Wells Fargo
Today's Analyst Rating | NVIDIA Price Target Raised to $189 by Evercore, Taiwan Semiconductor Price Target Raised to $240 by Barclays
CVS Health Shares Are Trading Higher After the Company Announced the Addition of Four New Directors to Its Board.
CVS Adds 4 New Board Members After Activist Push -- Barrons.com
CVS Health Adds Four New Directors Leslie Norwalk, Larry Robbins, Guy Sansone, and Doug Shulman After Discussing With Glenview Capital Management, Strengthening Board With Industry Veterans
Express News | CVS Health Corp - and Glenview Enter Confidentiality Agreement
Express News | CVS Health Corp - Board Now Comprises 16 Members
Express News | CVS Health Announces Board Appointments
Press Release: CVS Health Announces Board Appointments
CVS Adds to Board in Deal With Glenview -- WSJ
Hedge Fund Glenview Capital Had Amassed Large Stake in CVS -- WSJ
CVS Adds Four Board Members in Agreement With Investor Glenview Capital -- WSJ
New CVS Board Members Include Larry Robbins, CEO of Glenview Capital -- WSJ
Wells Fargo Upgrades CVS Health to Overweight From Equalweight, Adjusts Price Target to $66 From $60
Express News | CVS Health Corp : Leerink Partners Cuts Target Price to $57 From $63
RBC Capital has lowered the target price for CVS Health to $58.
RBC Capital: lowered the target price of CVS Health from $68 to $58, maintaining an "outperform large cap" rating. (Gelonghui)